GlassScriptPhysician profile
Sunil Kumar Reddy Thummala
NPI 1740418540
$22,874.95
in general payments reported to CMS, 2019-2025
53 companies · $2,092 in 2025
The $2,092 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $937 · 2021: $8,454 · 2022: $4,136 · 2023: $3,504 · 2024: $1,983 · 2025: $2,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,112 · Travel and Lodging: $1,400 · Education: $48.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,111.59 |
| Travel and Lodging | $1,400.33 |
| Education | $48.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,516.11 | 2020-2025 | Qulipta, Ubrelvy, Botox |
| Abbott Laboratories | $1,635.70 | 2022-2024 | Infinity, Proclaim |
| Emd Serono, INC. | $1,153.44 | 2019-2025 | Mavenclad |
| Sunovion Pharmaceuticals INC. | $968.08 | 2019-2022 | |
| Allergan, INC. | $897.23 | 2019-2021 | |
| Sk Life Science, INC. | $674.75 | 2021-2025 | |
| Livanova USA, INC. | $573.82 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $555.97 | 2019-2025 | Briviact, Rystiggo |
| Acadia Pharmaceuticals INC | $554.76 | 2019-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $524.72 | 2019-2025 | |
| Impel Pharmaceuticals INC. | $496.14 | 2023 | Trudhesa |
| Lundbeck LLC | $485.84 | 2019-2025 | Vyepti |
| Lilly USA, LLC | $440.45 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Boston Scientific Corporation | $408.91 | 2021-2025 | General - Dbs |
| Sumitomo Pharma America, INC. | $388.19 | 2023-2024 | Aptiom |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $387.05 | 2020-2025 | Rytary, Brekiya, Crexont |
| Biogen, INC. | $378.89 | 2021-2025 | Skyclarys, Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $327.16 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Avanir Pharmaceuticals, INC. | $322.03 | 2019-2022 | |
| Grifols USA, LLC | $315.36 | 2019-2025 | Gamunex-C |
| Aquestive Therapeutics, INC. | $304.55 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $303.49 | 2022 | |
| Pfizer INC. | $280.18 | 2021-2025 | |
| Mdd US Operations, LLC | $246.42 | 2022-2025 | Gocovri |
| Otsuka America Pharmaceutical, INC. | $216.93 | 2023-2025 | Rexulti, Nuedexta |
| Amgen INC. | $209.26 | 2019-2025 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $201.15 | 2021 | |
| Eisai INC. | $107.56 | 2019-2025 | |
| Genzyme Corporation | $96.07 | 2019-2022 | |
| Corium, LLC | $82.41 | 2023 | Adlarity |
| Axsome Therapeutics, INC. | $81.45 | 2025 | Symbravo |
| Greenwich Biosciences, INC. | $59.36 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $58.27 | 2022-2024 | Epidiolex |
| Ge Healthcare | $54.51 | 2019-2025 | |
| Genentech USA, INC. | $54.05 | 2024-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Neurelis, INC. | $52.25 | 2020-2021 | |
| Argenx US, INC. | $47.83 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Radius Health, INC. | $46.13 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $44.39 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $41.21 | 2021 | |
| Neurocrine Biosciences, INC. | $35.33 | 2024 | Ingrezza |
| Zyla Life Sciences, INC. | $34.74 | 2019 | |
| Impel Pharmaceuticals LLC | $23.06 | 2024 | Trudhesa |
| Avion Pharmaceuticals | $22.19 | 2023 | Dhivy |
| Celgene Corporation | $22.07 | 2023 | Zeposia |
| Springworks Therapeutics, INC. | $22.05 | 2025 | Gomekli |
| Kyowa Kirin, INC. | $22.05 | 2021 | |
| Upsher-Smith Laboratories LLC | $20.95 | 2020 | |
| Acorda Therapeutics, INC | $19.60 | 2019 | |
| Soleno Therapeutics, INC. | $16.49 | 2025 | Vykat Xr |
| Alexion Pharmaceuticals, INC. | $15.66 | 2019 | |
| Medtronic, INC. | $14.44 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Thummala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.